Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03760822
Title Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients (SOCRATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Federation Francophone de Cancerologie Digestive

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Paclitaxel + Ramucirumab


Age Groups: senior
Covered Countries FRA

No variant requirements are available.